These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 2881976)

  • 21. Autoradiographic localization of dopamine DA1 receptors in rat kidney with [3H]Sch 23390.
    Huo T; Healy DP
    Am J Physiol; 1989 Sep; 257(3 Pt 2):F414-23. PubMed ID: 2528915
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of the pharmacological characteristics of [3H]raclopride and [3H]SCH 23390 binding to dopamine receptors in vivo in mouse brain.
    Andersen PH
    Eur J Pharmacol; 1988 Jan; 146(1):113-20. PubMed ID: 2895008
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Autoradiographic localization of D1 dopamine receptors in the rat brain with [3H]SCH 23390.
    Savasta M; Dubois A; Scatton B
    Brain Res; 1986 Jun; 375(2):291-301. PubMed ID: 2942221
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [3H]SCH 39166, a new D1-selective radioligand: in vitro and in vivo binding analyses.
    McQuade RD; Duffy RA; Anderson CC; Crosby G; Coffin VL; Chipkin RE; Barnett A
    J Neurochem; 1991 Dec; 57(6):2001-10. PubMed ID: 1834801
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential localization of dopamine D1 and D2 receptors in rat retina.
    Tran VT; Dickman M
    Invest Ophthalmol Vis Sci; 1992 Apr; 33(5):1620-6. PubMed ID: 1532792
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evidence for different states of the dopamine D1 receptor: clozapine and fluperlapine may preferentially label an adenylate cyclase-coupled state of the D1 receptor.
    Andersen PH; Braestrup C
    J Neurochem; 1986 Dec; 47(6):1822-31. PubMed ID: 2945903
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Striatal D1- and D2-dopamine receptor sites are separately detectable in vivo.
    Leslie CA; Bennett JP
    Brain Res; 1987 Jul; 415(1):90-7. PubMed ID: 2957025
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Binding of [3H]SCH23390 in rat brain: regional distribution and effects of assay conditions and GTP suggest interactions at a D1-like dopamine receptor.
    Schulz DW; Stanford EJ; Wyrick SW; Mailman RB
    J Neurochem; 1985 Nov; 45(5):1601-11. PubMed ID: 2864398
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Binding of a novel dopaminergic agonist radioligand [3H]-fenoldopam (SKF 82526) to D-1 receptors in rat striatum.
    Flaim KE; Gessner GW; Crooke ST; Sarau HM; Weinstock J
    Life Sci; 1985 Apr; 36(15):1427-36. PubMed ID: 2858801
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 6-hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding.
    Breese GR; Duncan GE; Napier TC; Bondy SC; Iorio LC; Mueller RA
    J Pharmacol Exp Ther; 1987 Jan; 240(1):167-76. PubMed ID: 3100767
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Changes in apomorphine-induced stereotypy as a result of subacute neuroleptic treatment correlates with increased D-2 receptors, but not with increases in D-1 receptors.
    Fleminger S; Rupniak NM; Hall MD; Jenner P; Marsden CD
    Biochem Pharmacol; 1983 Oct; 32(19):2921-7. PubMed ID: 6138043
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Loss of rat striatal dopamine receptors with ageing is selective for D-2 but not D-1 sites: association with increased non-specific binding of the D-1 ligand [3H]piflutixol.
    O'Boyle KM; Waddington JL
    Eur J Pharmacol; 1984 Oct; 105(1-2):171-4. PubMed ID: 6149143
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The benzazepine, SCH 23390, inhibits 3H-NPA binding in mouse brain in vivo.
    Andersen PH; Nielsen EB
    Acta Pharmacol Toxicol (Copenh); 1986 Oct; 59(4):315-8. PubMed ID: 2948372
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of SKF 38393- and pergolide-induced circling in rats with unilateral 6-OHDA lesion is correlated to dopamine D-1 and D-2 receptor affinities in vitro.
    Arnt J; Hyttel J
    J Neural Transm; 1986; 67(3-4):225-40. PubMed ID: 2949056
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Different plasticity changes in D1 and D2 receptors in rat striatal subregions following impairment of dopaminergic transmission.
    Savasta M; Dubois A; Benavidès J; Scatton B
    Neurosci Lett; 1988 Feb; 85(1):119-24. PubMed ID: 2834672
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Striatal D1 dopamine receptor distribution following chemical lesion of the nigrostriatal pathway.
    Ariano MA
    Brain Res; 1988 Mar; 443(1-2):204-14. PubMed ID: 2965958
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Target size of dopamine D-1 receptors in rat corpus striatum estimated by binding of the benzazepine 3H-SCH 23390.
    Gredal O; Nielsen M; Hyttel J
    Pharmacol Toxicol; 1987 Apr; 60(4):255-7. PubMed ID: 2954035
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Autoradiographic identification of D1 dopamine receptors labelled with [3H]dopamine: distribution, regulation and relationship to coupling.
    Hervé D; Trovero F; Blanc G; Glowinski J; Tassin JP
    Neuroscience; 1992; 46(3):687-700. PubMed ID: 1532052
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chronic neuroleptic treatment increases D-2 but not D-1 receptors in rat striatum.
    MacKenzie RG; Zigmond MJ
    Eur J Pharmacol; 1985 Jul; 113(2):159-65. PubMed ID: 2864265
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vivo partial inactivation of dopamine D1 receptors induces hypersensitivity of cortical dopamine-sensitive adenylate cyclase: permissive role of alpha 1-adrenergic receptors.
    Trovero F; Hervé D; Blanc G; Glowinski J; Tassin JP
    J Neurochem; 1992 Jul; 59(1):331-7. PubMed ID: 1351927
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.